Abstract
Information is provided on efavirenz (Sustiva, formerly DMP-266), including dosage information, resistance and clinical trial results, and pharmacology. Side effects are reviewed, as are interactions with other anti-HIV drugs. Contact information is provided.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 6 |
| Number of pages | 1 |
| Journal | The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service |
| Volume | 11 |
| Issue number | 1 |
| State | Published - Jan 1999 |
ASJC Scopus subject areas
- General Medicine